TremRx Overview

  • Status
  • Out of Business
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Out of Business

TremRx General Information

Description

Developer of a proprietary technology platform designed to discover prophylactic and therapeutic vaccines. The company's platform develops effective vaccines that are delivered to the upper layers of skin rather than into muscle like conventional vaccines that can mediate a dramatically strong and effective immune response against viruses and bacteria, enabling users to stay healthy and build immunity.

Contact Information

Website
Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 67 Broad Street
  • Boston, MA 02109
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TremRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Mar-2019 Completed Out of Business
1. Seed Round Completed Startup
To view TremRx’s complete valuation and funding history, request access »

TremRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial